PMDA drug package insert
桂苓加大黄丸
PMDA OTC drug · （株）ウチダ和漢薬 · package insert May 16, 2022
Key facts
| Brand names | 桂苓加大黄丸 |
|---|---|
| Companies | 製造販売元／（株）ウチダ和漢薬 |
| Product type | OTC drug |
| OTC risk class | 第２類医薬品 |
| OTC dosage form | 錠剤 |
| OTC effect category | その他の漢方製剤 |
| Package insert date | May 16, 2022 |
| PMDA document key | 160040_J0601011041 |
| PMDA company code | 160040 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: